Wednesday, August 10, 2022
manilastandard.net
ADVERTISEMENT
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
manilastandard.net
No Result
View All Result
Home News World News

Pfizer strikes global licensing deal for cheap COVID-19 pill

AFPbyAFP
November 17, 2021, 7:10 pm
in World News
Reading Time: 3 mins read
A A
72
SHARES
Share on FacebookShare on TwitterShare on Email

US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral COVID-19 pill available more cheaply in the world’s least-wealthy countries.

Pfizer will sub-license production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent of the world’s population.

Under the deal struck with the global Medicines Patent Pool (MPP), Pfizer – which also produces one of the most widely-used COVID vaccines with German lab BioNTech – will not receive royalties from the generic manufacturers, making the treatment cheaper.

The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval.

The Pfizer drug is to be taken with the HIV medicine ritonavir.

ADVERTISEMENT

Interim data from ongoing trials demonstrated an 89 percent reduction in the risk of COVID-19-related hospitalisation or death compared to a placebo, in non-hospitalised high-risk adults with Covid-19 within three days of symptom onset, said Pfizer.

Similar results were seen within five days of symptom onset, it added.

The Geneva-based MPP is a United Nations-backed international organisation that works to facilitate the development of medicines for low- and middle-income nations.

If approved, the pill could be on the market in “a matter of months,” MPP policy chief Esteban Burrone told AFP.

Pfizer also said Tuesday that it was seeking an emergency use authorisation, or EUA, in the US for the COVID pill.

Pfizer will forego royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health Emergency of International Concern by the World Health Organization. AFP

Last month, the WHO maintained the highest level of alert over the spread of the SARS-CoV-2 virus that causes COVID-19.

Paxlovid, or PF-07321332, is an investigational antiviral therapy designed to block the activity of the SARS-CoV-2-3CL protease – an enzyme that the coronavirus needs to replicate.

Taking it together with a low dose of ritonavir helps slow the breakdown of PF-07321332. It, therefore, remains active in the body for a longer period at a high concentration, to help combat the virus.

The pill could potentially help patients avoid severe illness, which can lead to hospitalisation and death, Pfizer said.

“We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections, decreasing the strain on our healthcare systems and saving lives,” said Pfizer chairman and chief executive Albert Bourla.

While a multitude of vaccines have been rolled out in the pandemic, the hunt for treatments for those who have already caught the disease has not been as fruitful.

The MPP was founded by Unitaid, which works on innovations to prevent, diagnose and treat major diseases in poorer countries.

“During a pandemic, saving time means saving lives. This agreement could help us to reach more people more quickly as soon as the medicine is approved,” said Unitaid executive director Philippe Duneton.

Potential sublicensees have until December 6 to register an expression of interest.

The announcement comes after the MPP signed a similar voluntary licensing deal with Pfizer’s US rivals Merck & Co last month for its investigational oral antiviral medicine molnupiravir.

Subject to regulatory approval, the deal will help create broad access to molnupiravir in 105 low- and middle-income countries.

Pills are easier to make than vaccines, do not require a cold chain for delivery and can be self-administered by the patient.

In terms of relieving health systems by preventing hospitalisations, “it’s a game changer,” said Burrone.

He said pricing for the Pfizer pill had not yet been set but said that “in a competitive environment… the prices tend to come down” to a low level.

Doctors Without Borders (MSF) meanwhile suggested it might cost around $700 per Pfizer treatment course, in line with molnupiravir.

The medical charity said it was disheartened by the deal, saying restrictive voluntary licences were no substitute for guaranteed global access to COVID tools to bring the pandemic under control. 

Tags: antiviral pillBioNTechCOVID-19Medicines Patent PoolPfizer
ADVERTISEMENT
AFP

AFP

Related Posts

Biden signs key microchip bill into law

byAFP
August 10, 2022, 7:30 pm
0
131
Banaag assumes post as Bright Kindle director

WASHINGTON, United States—President Joe Biden signed into law Tuesday a multibillion dollar bill boosting domestic semiconductor and other high-tech manufacturing...

Read more

China warns it won’t tolerate ‘separatist’ acts in Taiwan

byAFP
August 10, 2022, 6:20 pm
0
132
Southwoods nails Seniors’ Fil golf crown

BEIJING—China on Wednesday vowed zero tolerance for “separatist activities” in Taiwan and reaffirmed that it would take the self-ruled island...

Read more

‘Russia aims to connect nuclear plant to Crimea’

byAFP
August 10, 2022, 6:15 pm
0
132
Southwoods nails Seniors’ Fil golf crown

KYIV—Russian forces occupying the Zaporizhzhia nuclear plant in southeast Ukraine are preparing to connect to Crimea, annexed by Moscow in...

Read more

US’ Biden signs ratification of bids of Sweden, Finland to NATO

byAFP
August 10, 2022, 6:10 pm
0
131
Southwoods nails Seniors’ Fil golf crown

WASHINGTON—President Joe Biden on Tuesday signed US ratification of bids by Finland and Sweden to enter NATO, taking expansion of...

Read more

Firefighters, helicopters battle to contain Matanzas fuel depot blaze

byAFP
August 10, 2022, 6:05 pm
0
131
Southwoods nails Seniors’ Fil golf crown

MATANZAS, Cuba—Helicopters and firefighters battled Tuesday to contain a days-old blaze at a fuel depot in Cuba that has already...

Read more

Austria in shock over doctor’s suicide following anti-vax protesters’ abuse

byAFP
August 10, 2022, 6:00 pm
0
132
Southwoods nails Seniors’ Fil golf crown

VIENNA—Austrians expressed shock and anger this week over the suicide of a doctor who had been the target of a...

Read more

Stories you may like

  • Zubiri new Senate President, vows to uphold chamber’s independence

    Marcos sees stronger PH-India relations

    5737 shares
    Share 2295 Tweet 1434
  • Showbiz icon Cherie Gil dies at 59

    2611 shares
    Share 1044 Tweet 653
  • Replevin and its common law origins

    1255 shares
    Share 502 Tweet 314
  • Fuel rollback next week, power rate cut in August

    1185 shares
    Share 474 Tweet 296
  • Getting into character: How the cast of ‘Maid in Malacañang’ prepared for their roles

    2776 shares
    Share 1110 Tweet 694

Print Edition

View More

Recent Posts

  • Andariel, a Lazarus subgroup, expands attacks with new ransomware 
  • Consumer inflation in China rises
  • In Norway, deactivated oil platforms get a second life
  • Biden signs key microchip bill into law
  • Cathay Pacific reduced first-half loss to US$637m
  • Buhain, COPA to bare plans at TOPS forum
  • Bollywood seeks boost with Tom Hanks movie remake
  • Sports on Air to discuss motorsports, boxing

Advertisement

Latest News

Buhain, COPA to bare plans at TOPS forum

byManila Standard Sports
August 10, 2022, 7:00 pm
0
132
Buhain, COPA to bare plans at TOPS forum

The current state of swimming and plans to further uplift the country’s grassroots sports program will be discussed as swimming...

Read more

Bollywood seeks boost with Tom Hanks movie remake

byAFP
August 10, 2022, 7:00 pm
0
128
Unraveling secrets in ‘Love You Stranger’ finale

One of India’s biggest stars is banking on a remake of Hollywood feel-good hit Forrest Gump to revive the fortunes...

Read more

Sports on Air to discuss motorsports, boxing

byManila Standard Sports
August 10, 2022, 6:55 pm
0
131
Sports on Air to discuss motorsports, boxing

Motorsports and boxing will be the main topics in the 33rd episode of “Sports on Air” on Thursday, August 11. ...

Read more

Sarah G, Mimiyuuuh together for epic collab

byManila Standard Showbiz
August 10, 2022, 6:50 pm
0
128
Unraveling secrets in ‘Love You Stranger’ finale

​​For the first time, value mobile brand TNT has brought together Popstar Sarah Geronimo and YouTube star Mimiyuuuh for an...

Read more

Unraveling secrets in ‘Love You Stranger’ finale

byManila Standard Showbiz
August 10, 2022, 6:40 pm
0
129
Unraveling secrets in ‘Love You Stranger’ finale

This week, the truth will set everyone free as Love You Stranger concludes the enthralling story about the legend of...

Read more

Advertisement

ADVERTISEMENT
Facebook Twitter Instagram Youtube

ABOUT US

Manila Standard

Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.

Digital Edition

In tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.

Download – Today’s Paper

Search

No Result
View All Result

6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines

Trunklines: 832-5554, 832-5556, 832-5558

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Pop.Life
    • Newsmakers
    • Hangouts
    • A-Pop
    • Post Its
    • Performances
    • Malls & Bazaars
    • Hobbies & Collections
  • Technology
    • Gadgets
    • Computers
    • Business
    • Tech Plus
  • MS ON THE ROAD
    • Sedan
    • SUV
    • Truck
    • Bike
    • Accessories
    • Motoring Plus
    • Commuter’s Corner
  • Home & Design
    • Residential
    • Commercial
    • Construction
    • Interior
  • Spotlight
  • Gallery
    • Photos
    • Videos
  • Events
    • Seminars
    • Exhibits
    • Community
  • Biyahero
    • Travel Features
    • Travel Reels
    • Travel Logs
  • Pets
  • Advertise with Us

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Install Manila Standard Web App

Install App